- Companies
- MojiaBio
MojiaBio Funding, Investors & Competitors
MojiaBio has raised $238M across 3 funding rounds, most recently a $80M Series B in June 2022.
Last MojiaBio funding round
$80M
Series B · Jun 2022
Cumulative funding MojiaBio raised
$238M
across 3 funding rounds
Key investors in MojiaBio
Bits x Bites
Asia Green Fund
Temasek
U.S.-China Green Fund
LYZZ Capital
Sento Investment
About MojiaBio
MojiaBio is a synthetic biology firm developing enzyme and metabolic engineering platforms to enhance biomanufacturing sustainability. Headquartered in China, the company optimizes chemical and petroleum processes by replacing polluting catalysts with bio-based alternatives, targeting industries like biofuels and fine chemicals. Its proprietary technologies enable higher yields and lower energy use in fermentation-based production of materials such as bioplastics and pharmaceuticals.
Founded
2018
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Licensing
MojiaBio Funding History
MojiaBio has raised a total of $238M across 3 funding rounds.
MojiaBio's first fundraising round was a $38M Series A in December 2020. The most recent completed round was a $80M Series B in June 2022.
MojiaBio funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jun 2022 | Series B | Temasek (lead); Sento Investment; LYZZ Capital; Asia Green Fund; Bits x Bites | $80M | Mojia Bio (also referred to as Mojia Biotech) is a Shanghai-based biomanufacturing company specializing in synthetic biology for green chemical production. It develops a proprietary platform for enzyme and metabolic engineering to produce bio-based ingredients and polymers, starting with vitamin B5 (animal feed additive) using renewable feedstocks that reduce energy use, waste, and emissions compared to petroleum-based methods. The company is expanding into biopolymer products for coating and adhesive applications, addressing supply chain vulnerabilities and China's environmental regulations. On June 23, 2022, Mojia Bio raised $80 million in a Series B round led by Temasek Holdings, with participation from Asia Green Fund, Bits x Bites, LYZZ Capital, and Sento Investment. The funds are allocated to commercialize bio-based animal feed additives like vitamin B5, scale biomanufacturing capacity, advance the product pipeline, and expand global R&D capabilities. Mojia Bio positions itself in the sustainable manufacturing sector, aiming to lead next-generation green chemical production amid global supply chain issues and the shift from fossil fuels. Investors like Bits x Bites highlight its potential to reduce import reliance and support a green economy through innovative bioprocesses. |
| Sep 2021 | Series A | Asia Green Fund (lead); U.S.-China Green Fund; Bits x Bites | $120M | MojiaBio is a Singapore-based startup specializing in green chemistry and sustainable biomanufacturing, developing proprietary technologies like Cn+Bio™ pathway and OrthBio® bioconversion process to convert low-cost renewable sources into bio-based molecules as alternatives to petroleum-based chemicals. The company focuses on producing eco-friendly products for various industries, positioning itself in the growing green chemicals market projected to reach USD 200 billion by 2030. Asia Green Fund, a private equity firm with about $2.0 billion in assets under management, has invested in MojiaBio across multiple rounds, including Series A and later Series B. A Series B round on June 23, 2022, raised $80M from investors including Temasek, Asia Green Fund, Bits x Bites, LYZZ Capital, and Sento Investment. Earlier rounds include Series A stages on 3/31/2021, 1/25/2021, and 8/23/2020, also involving Asia Green Fund in some cases. Post-Series B, MojiaBio partnered with Singapore's A*STAR on a S$44.8 million Sustainable Biomanufacturing Technology Platform (SBTP) announced around March 2025 to accelerate commercialization of green products like PDO, supported by Singapore's Green Plan 2030 for biobased chemicals. Asia Green Fund's 2023 and 2024 Green Impact Reports highlight MojiaBio (listed as MOJIABIO) among portfolio companies in green chemistry, emphasizing carbon reduction and sustainable transformation. The firm focuses on impactful investments in industrial upgrades via technological innovation, with MojiaBio noted alongside other greentech firms. |
| Dec 2020 | Series A | Asia Green Fund; Bits x Bites | $38M | Mojia Bio is a biotech company that has raised a total of $80M across 4 funding rounds, with investors including Asia Green Fund and Bits x Bites. Asia Green Fund participated in rounds from its first funding on 8/23/2020 through Series B in 2022. |
Who has invested in MojiaBio?
6 investors have backed MojiaBio across its funding rounds, including Bits x Bites, Asia Green Fund, Temasek, U.S.-China Green Fund, LYZZ Capital and Sento Investment.
Lead investors include Temasek and Asia Green Fund.
MojiaBio Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 3 | Lead | Dec 2020 | ||
| 3 | Participant | Dec 2020 | ||
| 1 | Lead | Jun 2022 | ||
| 1 | Participant | Jun 2022 | ||
This data is available for Pro users. Sign up to see all 6 MojiaBio investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialMojiaBio Competitors
MojiaBio competitors include listed companies like Borregaard, Tongwei and First Solar, and private ones like PhaBuilder, Absolute and Hydrosat.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $807M | $169M | $1.6B | 2.2x | ||
| Private | - | - | $287M | - | ||
| Publicly listed | $13B | $461M | $7.4B | 1.5x | ||
| Private | $210M | - | $500M | 2.4x | ||
| Private | - | - | $180M | - | ||
| Publicly listed | $5.2B | $2.1B | $22B | 4.0x |
MojiaBio Public Comps
MojiaBio is still privately-owned, but its public comps include First Solar, CF Industries, Qinghai Salt Lake Industry, Industries Qatar, SABIC Agri-Nutrient, Nextracker, Zhejiang NHU, Tongwei, Baosight and Jinko Solar.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $5.2B | $2.1B | 3.8x | 4.0x | 9.7x | 7.7x | |||
| $7.1B | $3.2B | 3.5x | 3.1x | 7.7x | 6.8x | |||
| $2.3B | $1.2B | 6.9x | 4.5x | 13.3x | 7.3x | |||
| $4.4B | $1.6B | 3.4x | 4.4x | 9.5x | 14.1x | |||
| $3.5B | $1.4B | 3.8x | 4.1x | 9.5x | 10.1x | |||
| $3.6B | $747M | 3.2x | 2.9x | 15.3x | 12.9x | |||
| $3.3B | $1.5B | 3.5x | 3.1x | 7.6x | 6.7x | |||
| $13B | $461M | 1.5x | 1.5x | 41.6x | 19.8x | |||
This data is available for Pro users. Sign up to see all MojiaBio competitors and their valuation data. Start Free Trial | ||||||||
Common questions about MojiaBio
| When was MojiaBio founded? | MojiaBio was founded in 2018. |
| Where is MojiaBio headquartered? | MojiaBio is headquartered in Guang'an, China. |
| Is MojiaBio publicly listed? | No, MojiaBio is a private, VC-backed company. |
| How much funding has MojiaBio raised? | MojiaBio has raised $238M across 3 funding rounds. |
| What was MojiaBio's last funding round? | MojiaBio's last funding round was a $80M Series B in June 2022, led by Temasek. |
| Who are MojiaBio's investors? | MojiaBio's investors include Asia Green Fund, Bits x Bites, Temasek, Sento Investment, LYZZ Capital and U.S.-China Green Fund. |
| Which companies are comparable to MojiaBio? | Companies comparable to MojiaBio include Borregaard, PhaBuilder, Tongwei, Absolute, Hydrosat and First Solar. |
See companies similar to MojiaBio
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




